Kolltan Pharmaceuticals
New Haven, US · Founded 2007 · 1 known investors
Founders & leadership
SC
Stanley ChoyNamed on SEC filing
AB
Axel BolteNamed on SEC filing
EJ
E. Jonathan SoderstromNamed on SEC filing
YH
Yaron HadariNamed on SEC filing
JS
Joseph SchlessingerNamed on SEC filing
AG
Arthur G. Altschul, Jr.Named on SEC filing
KP
K. Peter HirthNamed on SEC filing
TB
Thomas B. NeffNamed on SEC filing
MS
Michael SchmertzlerNamed on SEC filing
WB
W. Bradford MiddlekauffNamed on SEC filing
Investors · 1
Reported raises · per SEC filings
Form D private placements$85M disclosed across 2 rounds · 2012–2014
▶$60MraisedMar 2014 · 34 investors · BiotechnologyRule 506(b)
▶$60MraisedMar 2014 · 34 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- E. Jonathan SoderstromDirector
- Axel BolteDirector
- Paul MedeirosDirector
- K. Peter HirthDirector
- Stanley ChoyExecutive Officer
- Yaron HadariExecutive Officer
- Theresa M. LaValleeExecutive Officer
- Joseph SchlessingerDirector
- Carolyn F. SidorExecutive Officer
- Gerald McMahonExecutive Officer, Director
- Thomas B. NeffDirector
- Arthur G. Altschul, Jr.Director
- Jane Pritchett HendersonExecutive Officer
- Offering amount
- $60M
- Amount sold
- $60M
- First sale
- Mar 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$25MraisedMar 2012 · 1 investors · BiotechnologyRule 506(b)
▶$25MraisedMar 2012 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Stanley ChoyExecutive Officer
- Axel BolteDirector
- E. Jonathan SoderstromDirector
- Yaron HadariExecutive Officer
- Joseph SchlessingerDirector
- Arthur G. Altschul, Jr.Director
- K. Peter HirthDirector
- Thomas B. NeffDirector
- Michael SchmertzlerExecutive Officer, Director
- W. Bradford MiddlekauffExecutive Officer
- Offering amount
- $25M
- Amount sold
- $25M
- First sale
- Mar 2012
- Incorporated
- Corporation, Delaware, 2007
- Federal exemptions
- 06
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Kolltan Pharmaceuticals's investors?
- Kolltan Pharmaceuticals's investors include OUP (Osage University Partners).
- How much funding has Kolltan Pharmaceuticals raised?
- Kolltan Pharmaceuticals has disclosed $85M raised across 2 rounds.
- Where is Kolltan Pharmaceuticals headquartered?
- Kolltan Pharmaceuticals is headquartered in New Haven, US.